Impact of a high-monounsaturated-fat diet on lipid profile in subjects with type 1 diabetes

Journal of the American Dietetic Association

Volumn 103, Issue 4, 2003, Pages 467-474

  Strychar, Irene ^a   Ishac, Alain ^b   Rivard, Michèle ^b   Lussier Cacan, Suzanne ^c   Beauregard, Hugues ^a   Aris Jilwan, Nahla ^a   Radwan, Farouk ^a   Yale, Jean François ^d  

^a NOTRE DAME HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CHOLESTEROL; FAT; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MONOUNSATURATED FATTY ACID; VERY LOW DENSITY LIPOPROTEIN; EDIBLE OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD GLUCOSE MONITORING; CARBOHYDRATE DIET; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MALE; RANDOMIZATION; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; WILCOXON SIGNED RANKS TEST; BLOOD; DIABETIC DIET; DIET THERAPY; NONPARAMETRIC TEST; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION;

ADULT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC DIET; DIETARY CARBOHYDRATES; DIETARY FATS, UNSATURATED; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; LIPOPROTEINS; MALE; PATIENT COMPLIANCE; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES; WEIGHT LOSS;

EID: 0037676056     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1053/jada.2003.50066     Document Type: Article

References (49)

1. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 25:(suppl 1):2002;S5-S20.
2. Canadian Diabetes Association, Canadian Medical Association. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ. 159:(suppl 8):1998;159.
3. American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care. 25:(suppl 1):2002;S74-S77.
4. Fodor J.G., Frohlich J.J., Genest J.J.G., McPherson P.R. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias. CMAJ. 162:2000;1441-1447.
5. Koivisto V.A., Stevens L.K., Mattock M., Ebeling P., Muggeo M., Stephenson S., Idzior-Walus B. Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care. 19:1996;689-697.
6. Vergès B.L. Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Diabetes Metab (Paris). 25:(suppl 3):1999;32-40.
7. Rosental S.B., Ferrari N., Ruiz M., Wikinski R.L.W. Alterations in dense LDL subfractions in normolipidemic IDDM patients. APPTLA. 46:1996;185-192.
8. Manzato E., Zambon A., Zambon S., Nosadini R., Doria A., Marin R., Crepaldi G. Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients. Acta Diabetol. 30:1993;11-16.
9. Dunn F.L. Plasma lipid and lipoprotein disorders in IDDM. Diabetes. 41:(suppl 2):1992;102-106.
10. Taskinen M.R. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes. 41:(suppl 2):1992;12-17.
11. Canadian Diabetes Association. Guidelines for the nutritional management of diabetes mellitus in the new millennium (position statement). Can J Diabetes Care. 23:1999;56-69.
12. American Diabetes Association Position Statement. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care. 25:(suppl 1):2002;S50-S60.
13. American Diabetes Association Technical Review. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care. 25:(1):2002;148-198.
14. The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD) 1999. Recommendations for the nutritional management of patients with diabetes mellitus. Eur J Clin Nutr. 54:2000;353-355.
15. Parks E.J., Hellerstein M.K. Carbohydrate-induced hypertriacylglycerolemia: Historical perspective and review of biological mechanisms. Am J Clin Nutr. 71:2000;412-433.
16. Kris-Etherton P., Eckel R.H., Howard B.V., St. Jeor S., Bazzarre T.L., for the Nutrition Committee, Population Science Committee, Clinical Science Committee of the American Heart Association. Lyon Heart Study. Benefits of a mediterranean-style, National Cholesterol Education Program/American Heart Association step 1 dietary pattern on cardiovascular disease. Circulation. 103:2001;1823-1825.
17. Connor W.E., Connor S.L. Should a low-fat, high-carbohydrate diet be recommended for everyone? N Engl J Med. 337:1997;562-563.
18. Coulston A.M., Hollenbeck C.B., Swislocki A.L.M., Reaven G.M. Persistence of hypertriglyceridemic effects of low-fat high-carbohydrate diets in NIDDM patients. Diabetes Care. 12:1989;94-101.
19. Hollenbeck C.B., Connor W.E., Riddle M.C., Alaupovic P., Lecklem J.E. The effects of a high-carbohydrate low-fat, cholesterol-restricted diet on plasma lipid, lipoprotein, and apoprotein concentrations in insulin-dependent (type 1) diabetes mellitus. Metabolism. 34:1985;559-566.
20. Hollenbeck C.B., Riddle M.C., Connor W.E., Leklem J.E. The effects of subject-selected high-carbohydrate, low-fat diets on glycemic control in insulin dependent diabetes mellitus. Am J Clin Nutr. 41:1985;293-298.
21. Perrotti N., Santoro D., Genovese S., Giacco A., Rivellese A., Riccardi G. Effects of digestible carbohydrates on glucose control in insulin-dependent diabetic patients. Diabetes Care. 7:1984;354-359.
22. Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus: A meta-analysis. Am J Clin Nutr. 67:(suppl):1998;577S-582S.
23. Chen Y.D.I., Coulston A.M., Zhou M.Y., Hollenbeck C.B., Reaven G.M. Why do low-fat high-carbohydrate diets accentuate postprandial lipemia in patients with NIDDM? Diabetes Care. 18:1995;10-16.
24. Blades B., Garg A. Mechanisms of increase in plasma triglyceride concentrations as a result of high carbohydrate intakes in patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr. 62:1995;996-1002.
25. Garg A., Bantle J.P., Henry R.R., Coulston A.M., Griver K.A., Raatz S.K., Brinkley L., Chen Y.D.I., Grundy S.M., Huet B.A., Reaven G.M. Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. JAMA. 271:1994;1421-1428.
26. Garg A., Bonanome A., Grundy S.M., Zhang Z.J., Unger R.H. Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 319:1988;829-834.
27. Campbell L.V., Marmot P.E., Dyer J.A., Borkman M., Storlien L.H. The high-monounsaturated fat diet as a practical alternative for NIDDM. Diabetes Care. 17:1994;177-182.
28. Donaghue K.C., Pena M.M., Chan A.K.F., Blades B.L., King J., Storlien L.H., Silink M. Beneficial effects of increasing monounsaturated fat intake in adolescents with type 1 diabetes. Diabetes Res Clin Pract. 48:2000;193-199.
29. Georgopoulos A., Bantle J.P., Noutsou M., Swaim W.R., Parker S.J. Differences in the metabolism of postprandial lipoproteins after a high-monounsaturated-fat versus a high-carbohydrate diet in patients with type 1 diabetes mellitus. Arterioscler Thromb Vasc Biol. 18:1998;773-782.
30. Georgopoulos A., Bantle J.P., Noutsou M., Hoover H.A. A high carbohydrate versus a high monounsaturated fatty acid diet lowers the atherogenic potential of big VLDL particles in patients with type 1 diabetes. J Nutr. 130:2000;2503-2507.
31. Insel P., Turner R.E., Ross D. Nutrition. 2001;Jones and Bartlett Publishers, Sudbury, MA.
32. SantÉ QuÉbec, Bertrand L. sous la direction de (under the direction of)). Les QuEbEcoises et les QuEbEcois mangent-ils mieux? Rapport de l'EnquEte quEbEcoise sur la nutrition, 1990 (Are Quebecers eating better? Report of the Quebec nutrition survey, 1990. 1995;Ministère de la SantÉ et des Services sociaux, Gouvernement du QuÉbec, MontrÉal, QuÉbec.
33. Strychar I., Ghadirian P., Champagne F., Jenicek M., Bertrand L., Bonin A., Blain E., BrulÉ D., Thompson N., Lasater T. Procedures manual for the dietary assessment of the research project ″Health risk appraisal programs: impact of receiving blood cholesterol test results on dietary behaviors. 1994; : Notre-Dame Hospital, Montreal, Quebec.
34. Canadian Diabetes Association. Good Health Eating Guide Resource. 1996;Canadian Diabetes Association, Toronto, Ontario.
35. Thompson J.N. CANDI (Canadian Dietary Information System). Project E2311-213. 1995;Nutrition Research Division, Food Directorate, Health Protection Branch, Health Canada, Ottawa, Ontario. Version No. 4.0, upgraded with data from the 1997 Canadian Nutrient File.
36. US Department of Health, Education, and Welfare. Lipid Research Clinics Program: Manual of Laboratory Operations. Vol. 1:1982;US Government Printing Office, Washington, DC. Publication (NIH) 75-628.
37. Gidez L.I., Miller G.J., Burstein M., Slagle S., Eder H.A. Separation and quantitation of subclasses of human plasma high-density lipoproteins by a simple precipitation procedure. J Lipid Res. 23:1982;1206-1223.
38. Granger J.K., Passey R.B. Evaluating rate of immuno-nephelometric essays for apo A1 and apo B. Lab Med. 23:1992;539-542.
39. Krauss R.M., Burke D.J. Identification of multiple subclasses of plasma low-density lipoprotein in normal humans. J Lipid Res. 23:1982;97-104.
40. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J Biol Chem. 193:1951;265-275.
41. Esterbauer H., Striegl G., Puhl H., Rotheneder R. Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Free Radic Res Commun. 6:1989;67-75.
42. Senn S. Cross-Over Trials in Clinical Research. 1993;England: John Wiley, Chichester.
43. Cohn J.S. Postprandial lipemia: Emerging evidence for atherogenicity of remnant lipoproteins. Can J Cardiol. 14:1998;18B-27B.
44. Castro P., Lopez Miranda J.J., Gomez P., Escalante D.M., Lopez Segura F., Martin A., Fuentes F., Blanco A., Ordovas J.M., JimÉnez F.P. Comparison of an oleic acid enriched-diet vs NCEP-I diet on LDL susceptibility to oxidative modifications. Eur J Clin Nutr. 63:2000;61-67.
45. Kris-Etherton P.M., Pearson T.A., Wan Y., Hargrove R.L., Moriarty K., Fishell V., Etherton T.D. High-monounsaturated fatty acid diets lower both plasma cholesterol and triglyceride concentrations. Am J Clin Nutr. 70:1999;1009-1015.
46. Abbey M., Bryan-Belling G., Noakes M., Hirata F., Nestel P.J. Oxidation of low-density lipoproteins: Intraindividual variability and the effect of dietary linolate supplementation. Am J Clin Nutr. 57:1993;391-398.
47. Berry E.M., Eisenberg S., Friedlander Y., Harats D., Kaufmann N.A., Norman Y., Stein Y. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins-the Jerusalem Nutrition Study. II Monounsaturated fatty acids vs carbohydrates. Am J Clin Nutr. 56:1992;394-403.
48. Reaven P., Parthasarathy S., Grasse B.J., Miller E., Almazan F., Mattson F.H., Khoo J.C., Steinberg D., Witztum J.L. Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans. Am J Clin Nutr. 54:1991;701-706.
49. Lloyd H.M., Paisley C.M., Mela D.J. Barriers to the adoption of reduced-fat diets in a UK population. J Am Diet Assoc. 95:1995;316-322.